TABLE 1.
Patients’ characteristics.
| Critical (n = 25) |
Moderate (n = 95) |
Critical (n = 25) |
Moderate (n = 95) |
||
| Age | BMI | ||||
| Median (range) | 60 (34–91) | 54 (19–86) | < 18.5 (underweight) | 0 (0%) | 3 (3.16%) |
| 0–19 (%) | 0 (0%) | 1 (1.05%) | 18.5–24.9 (normal weight) | 1 (4.00%) | 14 (14.74%) |
| 20–29 (%) | 0 (0%) | 5 (5.26%) | 25–29.9 (overweight) | 5 (20.00%) | 22 (23.16%) |
| 30–39 (%) | 3 (12.00%) | 17 (17.89%) | 30–34.9 (obesity Class I) | 7 (28.00%) | 25 (26.32%) |
| 40–49 (%) | 3 (12.00%) | 15 (15.79%) | 35–39.9 (obesity Class II) | 7 (28.00%) | 19 (20.00%) |
| 50–59 (%) | 6 (24.00%) | 23 (24.21%) | > 40 (obesity Class III) | 4 (16.00%) | 11 (11.58%) |
| 60–69 (%) | 7 (28.00%) | 16 (16.84%) | Unknown | 1 (4.00%) | 1 (1.05%) |
| 70–79 (%) | 2 (8.00%) | 14 (14.74%) | Comorbidities | ||
| 80–100 (%) | 4 (16.00%) | 4 (4.21%) | Diabetic | 12 (48.00%) | 28 (29.47%) |
| Sex | CKD | 6 (24.00%) | 13 (13.68%) | ||
| Female | 13 (52.00%) | 44 (46.32%) | COPD | 5 (20.00%) | 14 (14.74%) |
| Male | 12 (48.00%) | 51 (53.68%) | Cancer | 5 (20.00%) | 23 (24.21%) |
| Ethnicity | HD | 14 (56.00%) | 29 (30.53%) | ||
| Hispanic or Latino | 15 (60.00%) | 49 (51.58%) | Obesity | 7 (28.00%) | 29 (30.53%) |
| African American | 1 (4.00%) | 1 (1.05%) | Blood result median (range) | ||
| White | 13 (52.00%) | 45 (47.37%) | Leukocyte count (×10∧3/μl, 4.00–10.50) | 7.83 (3.04–18.63) | 6.92 (0.45–15.25) |
| Other or unknown | 1 (4.00%) | 3 (3.16%) | Platelets (×10∧3/μl, 140–400) | 225.96 (113.5–397.5) | 231.97 (11–611.75) |
| Non-Hispanic or Latino | 9 (36.00%) | 44 (46.32%) | Hemoglobin (g/dL, male = 13.3–16.3, female = 11.1–14.6) | 12.59 (8.325–15.55) | 11.87 (6.77–15.5) |
| African American | 8 (32.00%) | 28 (29.47%) | C-reactive protein (mg/dL, 0–0.5)* | 9.88 (0.93–29.5) | 6.88 (0.3–31.2) |
| White | 1 (4.00%) | 15 (15.79%) | Alanine aminotransferase (U/L, male = 0–41, female = 0–33) | 42.02 (13.33–115.33) | 53.29 (7.5–323.33) |
| Other or unknown | 0 (0%) | 1 (1.05%) | Lactose dehydrogenase (U/L, male = 135–225, female = 135–214)* | 456.44 (199.67–720) | 385.85 (142–1,578.5) |
| Ethnicity unknown | 1 (4.00%) | 2 (2.11%) | D-dimer (ug/ml, < 0.50) | 2.06 (0.4–10.8) | 2.4 (0.3–18.45) |
| African American | 0 (0%) | 2 (2.11%) | NLR (ratio of neutrophils to lymphocyte)* | 7.37 (1.04–19.9) | 6.65 (0.63–81.74) |
| Other or unknown | 1 (4.00%) | 0 (0%) | LMR (ratio of lymphocyte to monocyte) | 2.46 (0.75–7.5) | 3.1 (0.54–34.5) |
| WBC count (×10∧3/μl, 4–10.50) | 7.83 (18.63–2.04) | 6.93 (15.25–0.45) | |||
*Indicates a significant difference between the 2 severity groups.